United States · Who invested in Oncology Analytics?
Oncology Analytics's investors include Blue Cross Blue Shield, Oak HC/FT/ McKesson and Sandbox Advantage.
United States · Series B startup
Who invested in Oncology Analytics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$21Mraised across 1 round since 2018, from 1 source
- Latest round
- Series B, $21MNov 2018
- Investors
- 3
The rounds
- Nov 2018Series B$21M
- Blue Cross Blue Shield
- Oak HC/FT/ McKesson
- Sandbox Advantage
Reported by FinSMEsSEC filing: $21M sold, first sale Oct 2018
Founders and team
From the SEC filings it signed: 2 on the team.
- Marc J. FishmanExecutive Officer, Directori
- Rick J. DeanExecutive Officer, Directori
On the board, as filediAnn J. LamontMichael J. LiangMichael J. WeintraubPeter J. BachThomas J. HawesZeke J. Emanuel
Quick answers about Oncology Analytics
How much has Oncology Analytics raised?
Oncology Analytics has raised $21M across 1 round since 2018.
When did Oncology Analytics last raise?
Oncology Analytics's most recent round was a Series B of $21M in Nov 2018.
What was Oncology Analytics's biggest round?
Its most recent round, $21M in Nov 2018, is also its largest on record.
Who backed Oncology Analytics first?
Oncology Analytics's first round on record, in Nov 2018, was backed by Blue Cross Blue Shield, Oak HC/FT/ McKesson and Sandbox Advantage.
What stage is Oncology Analytics at?
Oncology Analytics's latest named round is a Series B, in Nov 2018.
Where is Oncology Analytics based?
Oncology Analytics is based in the United States.
Companies like Oncology Analytics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.